림프세포증식성 질환에서 효과를 보인 부분적 비동맥 색전술 1례 = Successful Treatment with Partial Splenic Embolization in a Case of Post-transplantations Lymphoproliferative Disease with Persistent Hypersplenism

다국어 초록 (Multilingual Abstract)

Posttranplantations lymphoproliferative disease (PTLD) is a common and life-threatening complication for soid organ transplantation associated with the use of chronic immunosuppression and Epstein-Barr virus. There is no standardized treatment algorithm, but numerous management strategies are vaiable. Partial splenic embolization (PSE) had been demonstrated to be an effetive alternatie to splenectomy for patients hypersplenism and portal hypertension. PSE has the advantages of non-invasive intervention and resolution of the complications of hypersplenism. We report the effect of the PSE in a 6-year old male liver transplantation recepient with PTLD who has undergone persistent hypersplenism post-transplant. We reduced immunosuppression agent, started antiviral agent. We started with interferon and IV globulin one month after admission. Hepatosplenomegaly and cervical lymphadenopathy were improved. But fever was not subside. We selectively embolized the lower pole of the spleen to achieve a 50~60% reduction in flow as determined by angiography. After embolization, fever subside and peripheral blood findings were improved. Follow up abdominal CT revealed reduced volume of spleen due to ischemic change and there was no multiple enlarged mesenteric lymphnode compared to preembolization state. We thick that PSE is a safe an effetive treatment modality of PTLD with persistent hypersplenism in patients twho failed to medical treatment.

참고문헌 (Reference)

1 "Two cases of posttransplant lymphoproliferative disorders in recipients of liver transplantation" 56 : 399-402, 1999

2 "The role of immunosuppression in lymphoma formation" 20 : 343-355, 1998

3 "The involvement of the gastrointestinal tract in posttransplant lymphoproliferative disease in pediatric liver transplantation" 28 : 380-385, 1999

4 "The frequency of Epstein-Barr virus infection and associated lymphoproliferative syndrome after transplantation,and its manifestations in children" 45 : 719-27, 1988

5 "The antiviral prophylaxis of posttransplant lymphoproliferative disorder" 20 : 437-453, 1998

6 "Post-transplant lymphoproliferative disease in children" 154 : 250-257, 2001

7 "Partial splenic embolization:long-term outcome" 387 : 421-426, 2003

8 "Partial splenic embolization for hypersplenism before and after transplantation" 16 (16): 59-61, 2002

9 "Lymphoproliferative disorders after organ transplantation in children" 67 : 990-998, 1999

10 "Lymphoproliferative disease after lung transplantation in transplanted lung" 34 : 956-959, 2001

11 "Long-term results of initial and repeated partial splenic embolizaton for the treatment of chronic idiopathic thrombocytopenic purpura" 179 : 1323-1326, 2002

12 "Long-term hematolgical and biochemical effects of partial splenic embolization in hepatic cirrhosis" 49 : 1445-1448, 2002

13 "Interferon-α treatment posttransplant lymphoproliferative disorder in recipients of solid organ transplants" 66 : 1770-1779, 1998

14 "Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation" 69 : 9982-9984, 2001

15 "Expression of Epstein-Barr virus-encoded small RNA(by the EBER- 1 gene)in liver specimens from transplant recipients with post-transplantation lymphoproliferative disease" 327 : 1710-4, 1992

16 "Epstein-Barr virus and post- transplant lymphoproliferative disease" 6 : 456-464, 2002

17 "Embolization of the spleen for treatment of splenomegaly and hypersplenism in patients with portal hypertension" 14 : 457-64, 1979

18 "Changes in portal hemodynamics and hepatic function after partial splenic embolization" 33-41,

19 "An increased incidence of Epstein-Barr virus infection and lymphoproliferative disorder in young children on FK 506 after liver transplantation" 59 : 524-529, 1995

20 "A case of posttransplant lymphoproliferative disease(PTLD)following renal transplantation in a child" 6 : 123-130, 2002